BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 19618317)

  • 1. Atorvastatin reduces sympathetic activity and increases baroreceptor reflex sensitivity in patients with hypercholesterolaemia and systemic arterial hypertension.
    Siński M; Lewandowski J; Ciarka A; Bidiuk J; Abramczyk P; Dobosiewicz A; Gaciong Z
    Kardiol Pol; 2009 Jun; 67(6):613-20. PubMed ID: 19618317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin reduces sympathetic activity in men with hypertension and hypercholesterolemia.
    Lewandowski J; Siński M; Bidiuk J; Abramczyk P; Dobosiewicz A; Ciarka A; Gaciong Z
    Hypertens Res; 2010 Oct; 33(10):1038-43. PubMed ID: 20668455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Atorvastatin dreduces sympathetic activity and improves baroreceptor reflex sensitivity in patients with hypercholesterolemia and hypertension].
    Raczak G
    Kardiol Pol; 2009 Jun; 67(6):621-2. PubMed ID: 19852090
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of atorvastatin on aortic pulse wave velocity in patients with hypertension and hypercholesterolaemia: a preliminary study.
    Raison J; Rudnichi A; Safar ME
    J Hum Hypertens; 2002 Oct; 16(10):705-10. PubMed ID: 12420194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of the immune system in primary hypercholesterolaemia: effect of atorvastatin therapy.
    Sampietro T; Bigazzi F; Rossi G; Dal Pino B; Puntoni MR; Sbrana F; Chella E; Bionda A
    J Intern Med; 2005 Jun; 257(6):523-30. PubMed ID: 15910556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose atorvastatin reduces ambulatory blood pressure in patients with mild hypertension and hypercholesterolaemia: a double-blind, randomized, placebo-controlled study.
    Kanaki AI; Sarafidis PA; Georgianos PI; Stafylas PC; Kanavos K; Tziolas IM; Lasaridis AN
    J Hum Hypertens; 2012 Oct; 26(10):577-84. PubMed ID: 21881597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin reduces sympathetic activity in patients with chronic kidney disease.
    Siddiqi L; Joles JA; Oey PL; Blankestijn PJ
    J Hypertens; 2011 Nov; 29(11):2176-80. PubMed ID: 21897294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic patients with insulin resistance.
    Fogari R; Derosa G; Lazzari P; Zoppi A; Fogari E; Rinaldi A; Mugellini A
    Am J Hypertens; 2004 Sep; 17(9):823-7. PubMed ID: 15363826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salt supresses baseline muscle sympathetic nerve activity in salt-sensitive and salt-resistant hypertensives.
    Abrahão SB; Tinucci T; Santello JL; Mion D
    J Hum Hypertens; 2002 Dec; 16(12):843-50. PubMed ID: 12522465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of atorvastatin on red-blood cell Na(+)/Li(+) countertransport in hyperlipidemic patients with and without hypertension.
    Kosmidou MS; Hatzitolios AI; Adamidou A; Giannopoulos S; Raikos N; Parharidis G; Milionis HJ
    Am J Hypertens; 2008 Mar; 21(3):303-9. PubMed ID: 18202666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart disease.
    Conard SE; Bays HE; Leiter LA; Bird SR; Rubino J; Lowe RS; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2008 Dec; 102(11):1489-94. PubMed ID: 19026302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistant arterial hypertension and hyperlipidemia: atorvastatin, not vitamin C, for blood pressure control.
    Magen E; Viskoper R; Mishal J; Priluk R; Berezovsky A; Laszt A; London D; Yosefy C
    Isr Med Assoc J; 2004 Dec; 6(12):742-6. PubMed ID: 15609886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin reduces platelet-oxidized-LDL receptor expression in hypercholesterolaemic patients.
    Puccetti L; Sawamura T; Pasqui AL; Pastorelli M; Auteri A; Bruni F
    Eur J Clin Invest; 2005 Jan; 35(1):47-51. PubMed ID: 15638819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of ezetimibe added on to atorvastatin (40 mg) compared with uptitration of atorvastatin (to 80 mg) in hypercholesterolemic patients at high risk of coronary heart disease.
    Leiter LA; Bays H; Conard S; Bird S; Rubino J; Hanson ME; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2008 Dec; 102(11):1495-501. PubMed ID: 19026303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal muscle metaboreflex control of sympathetic activity in never-treated hypertensive subjects.
    Rondon MU; Laterza MC; de Matos LD; Trombetta IC; Braga AM; Roveda F; Alves MJ; Krieger EM; Negrão CE
    Am J Hypertens; 2006 Sep; 19(9):951-7. PubMed ID: 16942939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients.
    Bloomfield D; Carlson GL; Sapre A; Tribble D; McKenney JM; Littlejohn TW; Sisk CM; Mitchel Y; Pasternak RC
    Am Heart J; 2009 Feb; 157(2):352-360.e2. PubMed ID: 19185645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of atorvastatin on LDL & hs-CRP in a selected Thai population.
    Boonbaichaiyapruck S; Cheepudomwit S; Panjavenin P; Suthichaiyakul T; Moleelerkpoom W; Benjanuwatra T; Sukanandachai B; Buakhamsri A
    J Med Assoc Thai; 2008 Aug; 91(8):1189-95. PubMed ID: 18788689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baroreflex sensitivity in essential and secondary hypertension.
    Mussalo H; Vanninen E; Ikäheimo R; Laitinen T; Laakso M; Länsimies E; Hartikainen J
    Clin Auton Res; 2002 Dec; 12(6):465-71. PubMed ID: 12598951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute arterio-venous fistula occlusion decreases sympathetic activity and improves baroreflex control in kidney transplanted patients.
    Velez-Roa S; Neubauer J; Wissing M; Porta A; Somers VK; Unger P; van de Borne P
    Nephrol Dial Transplant; 2004 Jun; 19(6):1606-12. PubMed ID: 15034165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of atorvastatin and pravastatin on glucose tolerance, adipokine levels and inflammatory markers in hypercholesterolaemic patients.
    Ando H; Sugimoto K; Yanagihara H; Tsuruoka S; Saito T; Takamura T; Kaneko S; Fujimura A
    Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1012-7. PubMed ID: 18430053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.